These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7156513)
1. Measurement of the cell loss from two spontaneous canine tumours. Holmes JM Res Vet Sci; 1982 Nov; 33(3):375-7. PubMed ID: 7156513 [TBL] [Abstract][Full Text] [Related]
2. A 125IUdR technique for measuring the cell loss from subcutaneously growing canine transmissible venereal tumours. Holmes JM Res Vet Sci; 1981 Nov; 31(3):306-11. PubMed ID: 7342225 [TBL] [Abstract][Full Text] [Related]
3. Measurement of the rate of death of canine transmissible venereal tumour cells transplanted into dogs and nude mice. Holmes JM Res Vet Sci; 1981 Mar; 30(2):248-50. PubMed ID: 7255917 [TBL] [Abstract][Full Text] [Related]
4. Expression of c-yes oncogene product in various animal tissues and spontaneous canine tumours. Rungsipipat A; Tateyama S; Yamaguchi R; Uchida K; Miyoshi N Res Vet Sci; 1999 Jun; 66(3):205-10. PubMed ID: 10333460 [TBL] [Abstract][Full Text] [Related]
5. A survey on neoplasia in domestic species over a 40-year period from 1935 to 1974 in the Republic of South Africa. VI. Tumours occurring in dogs. Bastianello SS Onderstepoort J Vet Res; 1983 Sep; 50(3):199-220. PubMed ID: 6646663 [TBL] [Abstract][Full Text] [Related]
6. Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumours. Wergin MC; Kaser-Hotz B In Vivo; 2004; 18(1):15-9. PubMed ID: 15011746 [TBL] [Abstract][Full Text] [Related]
7. Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures. Von Euler H; Khoshnoud R; He Q; Khoshnoud A; Fornander T; Rutqvist LE; Skog S Int J Mol Med; 2005 Dec; 16(6):979-85. PubMed ID: 16273275 [TBL] [Abstract][Full Text] [Related]
8. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645 [TBL] [Abstract][Full Text] [Related]
9. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. Taylor F; Gear R; Hoather T; Dobson J J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421 [TBL] [Abstract][Full Text] [Related]
10. Cell production rates in human tissues and tumours and their significance. Part II: clinical data. Rew DA; Wilson GD Eur J Surg Oncol; 2000 Jun; 26(4):405-17. PubMed ID: 10873364 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours. Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888 [TBL] [Abstract][Full Text] [Related]
12. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231 [TBL] [Abstract][Full Text] [Related]
13. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344 [TBL] [Abstract][Full Text] [Related]
14. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337 [TBL] [Abstract][Full Text] [Related]
15. Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations. Rew DA; Wilson GD Eur J Surg Oncol; 2000 Apr; 26(3):227-38. PubMed ID: 10753534 [TBL] [Abstract][Full Text] [Related]
16. Interrelation of directly measured oxygenation levels, erythropoietin and erythropoietin receptor expression in spontaneous canine tumours. Rohrer Bley C; Wergin M; Roos M; Grenacher B; Kaser-Hotz B Eur J Cancer; 2007 Mar; 43(5):963-7. PubMed ID: 17254768 [TBL] [Abstract][Full Text] [Related]
17. [Determination of the potential doubling time of tumors using bromodeoxyuridine and flow cytometry]. Schwyn U; Kaser-Hotz B; Hauser B; Fodor G; Ruckstuhl H; Crompton NE Schweiz Arch Tierheilkd; 1997; 139(10):441-8. PubMed ID: 9441381 [TBL] [Abstract][Full Text] [Related]
18. The role of hypoxia in canine cancer. Snyder SA; Dewhirst MW; Hauck ML Vet Comp Oncol; 2008 Dec; 6(4):213-23. PubMed ID: 19178681 [TBL] [Abstract][Full Text] [Related]
19. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. Kiupel M; Webster JD; Miller RA; Kaneene JB J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909 [TBL] [Abstract][Full Text] [Related]
20. Canine mammary tumour cell lines established in vitro. Hellmén E J Reprod Fertil Suppl; 1993; 47():489-99. PubMed ID: 8229968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]